Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 86

    1.

    Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: A review.

    Topp L, Day C, Dore GJ, Maher L.

    Drug Alcohol Rev. 2009 Nov;28(6):669-75.PMID: 19930022 [PubMed - in process]

    2.

    The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.

    Gidding HF, Topp L, Middleton M, Robinson K, Hellard M, McCaughan G, Maher L, Kaldor JM, Dore GJ, Law MG.

    J Gastroenterol Hepatol. 2009 Oct;24(10):1648-54.PMID: 19798783 [PubMed - in process]Related articles

    3.

    Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection.

    Dore GJ, Hellard M, Matthews G, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White P, French R, Rawlinson W, Lloyd AR, Kaldor JM; Australian Trial In Acute Hepatitis C Study Group.

    Gastroenterology. 2009 Sep 24. [Epub ahead of print]PMID: 19782085 [PubMed - as supplied by publisher]Related articles

    4.

    IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.

    Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Müller T, Bahlo M, Stewart GJ, Booth DR, George J.

    Nat Genet. 2009 Oct;41(10):1100-4. Epub 2009 Sep 13.PMID: 19749758 [PubMed - indexed for MEDLINE]Related articles

    5.

    Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.

    Roberts SK, Weltman MD, Crawford DH, McCaughan GW, Sievert W, Cheng WS, Rawlinson W, Desmond PV, Marks PS, Yoshihara M, Rizkalla B, Depamphilis JK, Dore GJ; Chariot Study Group.

    Hepatology. 2009 Oct;50(4):1045-55.PMID: 19676125 [PubMed - indexed for MEDLINE]Related articles

    6.

    HCV reinfection studies and the door to vaccine development.

    Grebely J, Thomas DL, Dore GJ.

    J Hepatol. 2009 Oct;51(4):628-31. Epub 2009 Jul 17. No abstract available. PMID: 19660823 [PubMed - in process]Related articles

    7.

    Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.

    Matthews GV, Seaberg E, Dore GJ, Bowden S, Lewin SR, Sasadeusz J, Marks P, Goodman Z, Philp FH, Tang Y, Locarnini S, Thio CL.

    AIDS. 2009 Aug 24;23(13):1707-15.PMID: 19584701 [PubMed - in process]Related articles

    8.

    Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection.

    Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJ, Revill P, Iser D, Slavin J, Buranapraditkun S, Marks P, Matthews G, Cooper DA, Kent SJ, Cameron PU, Sasadeusz J, Desmond P, Locarnini S, Dore GJ, Ruxrungtham K, Lewin SR.

    J Virol. 2009 Aug;83(15):7649-58. Epub 2009 May 20.PMID: 19458009 [PubMed - indexed for MEDLINE]Related articles

    9.

    Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study.

    Doab A, Topp L, Day CA, Dore GJ, Maher L.

    Contemp Clin Trials. 2009 Sep;30(5):431-5. Epub 2009 Apr 16.PMID: 19376270 [PubMed - in process]Related articles

    10.

    Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.

    Robotin MC, Kansil M, Howard K, George J, Tipper S, Dore GJ, Levy M, Penman AG.

    J Hepatol. 2009 May;50(5):990-8. Epub 2009 Feb 15.PMID: 19303657 [PubMed - indexed for MEDLINE]Related articles

    11.

    Arterial pulse wave velocity and cognition with advancing age.

    Elias MF, Robbins MA, Budge MM, Abhayaratna WP, Dore GA, Elias PK.

    Hypertension. 2009 Apr;53(4):668-73. Epub 2009 Feb 23.PMID: 19237680 [PubMed - indexed for MEDLINE]Related articles

    12.

    Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.

    Crane M, Oliver B, Matthews G, Avihingsanon A, Ubolyam S, Markovska V, Chang JJ, Dore GJ, Price P, Visvanathan K, French M, Ruxrungtham K, Lewin SR.

    J Infect Dis. 2009 Apr 1;199(7):974-81.PMID: 19231993 [PubMed - indexed for MEDLINE]Related articles

    13.

    Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.

    Nguyen VT, Amin J, Law MG, Dore GJ.

    J Gastroenterol Hepatol. 2009 Mar;24(3):436-42. Epub 2008 Oct 21.PMID: 19175834 [PubMed - indexed for MEDLINE]Related articles

    14.

    Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy.

    Lewin SR, Ribeiro RM, Avihingsanon A, Bowden S, Matthews G, Marks P, Locarnini SA, Ruxrungtham K, Perelson AS, Dore GJ.

    Hepatology. 2009 Apr;49(4):1113-21.PMID: 19115219 [PubMed - indexed for MEDLINE]Related articles

    15.

    Brain indices predict blood pressure control: aging brains and new predictions.

    Elias MF, Dore GA.

    Hypertension. 2008 Dec;52(6):1014-5. Epub 2008 Nov 3. No abstract available. PMID: 18981318 [PubMed - indexed for MEDLINE]Related articles

    16.

    Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study.

    Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, Klein MB, Dore GJ, Mocroft A, Soriano V, Clotet B, Lundgren JD; SMART Study Group and International Network for Strategic Initiatives in Global HIV Trials (INSIGHT).

    Clin Infect Dis. 2008 Dec 1;47(11):1468-75.PMID: 18959492 [PubMed - indexed for MEDLINE]Related articles

    17.

    Tell me it ain't so: patient-to-patient transmission of hepatitis C in an endoscopy clinic.

    Dore GJ, Haber PS.

    Hepatology. 2008 Oct;48(4):1333-5.PMID: 18821606 [PubMed]Related articles

    18.
    19.

    HIV and hepatitis C coinfection.

    Matthews GV, Dore GJ.

    J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1000-8. Review.PMID: 18707597 [PubMed - indexed for MEDLINE]Related articles

    20.

    A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.

    Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P, Marks P, Sasadeusz J, Cooper DA, Bowden S, Locarnini S, Ruxrungtham K, Dore GJ.

    Hepatology. 2008 Oct;48(4):1062-9.PMID: 18697216 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...